Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
The Long Run with Luke Timmerman
00:00
Biotec - What's Next for Biotec?
Raymond Sounotobit is the founder and CEO of a biotechnology company. The company has two molecules in the clinic right now, with plans to have another one later this year or early next year. "My measure of success for shote number of patients that we treat" will be his metric for success," he says.
Transcript
Play full episode
